| 10.76 -0.04 (-0.37%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 13.08 | 1-year : | 15.27 |
| Resists | First : | 11.19 | Second : | 13.08 |
| Pivot price | 10.86  |
|||
| Supports | First : | 10.59 | Second : | 10.22 |
| MAs | MA(5) : | 10.82 |
MA(20) : | 10.93 |
| MA(100) : | 10.84 |
MA(250) : | 9.68 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 62.4 |
D(3) : | 63.3 |
| RSI | RSI(14): 42.6 |
|||
| 52-week | High : | 11.8 | Low : | 7.82 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ENFN ] has closed above bottom band by 36.8%. Bollinger Bands are 0.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.88 - 10.95 | 10.95 - 11 |
| Low: | 10.58 - 10.66 | 10.66 - 10.72 |
| Close: | 10.65 - 10.77 | 10.77 - 10.86 |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Sun, 18 Jan 2026
The Truth About Enfusion Inc: Why Everyone on Wall Street Is Suddenly Watching ENFN - AD HOC NEWS
Tue, 06 Jan 2026
The Truth About Enfusion Inc: Is ENFN the Sleeper Stock Everyone’s Sleeping On? - AD HOC NEWS
Mon, 21 Apr 2025
Enfusion Completes Merger with Clearwater, Delists from NYSE - TipRanks
Mon, 21 Apr 2025
$1.5B Fintech Merger: Clearwater Analytics Creates First Unified Front-to-Back Investment Platform - Stock Titan
Mon, 21 Apr 2025
Clearwater completes Enfusion acquisition, unifies investment tech By Investing.com - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 95 (M) |
| Shares Float | 46 (M) |
| Held by Insiders | 4.7 (%) |
| Held by Institutions | 96.2 (%) |
| Shares Short | 1,300 (K) |
| Shares Short P.Month | 948 (K) |
| EPS | 0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.76 |
| Profit Margin | 1.3 % |
| Operating Margin | 2.9 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | 4.4 % |
| Qtrly Rev. Growth | 13.8 % |
| Gross Profit (p.s.) | 1.44 |
| Sales Per Share | 2.12 |
| EBITDA (p.s.) | 0.13 |
| Qtrly Earnings Growth | -81.9 % |
| Operating Cash Flow | 35 (M) |
| Levered Free Cash Flow | 24 (M) |
| PE Ratio | 358.66 |
| PEG Ratio | 0 |
| Price to Book value | 13.97 |
| Price to Sales | 5.05 |
| Price to Cash Flow | 29.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|